Abstract:ID 96167 Poster Board 483 The escalating global prevalence of inflammatory bowel diseases (IBDs), comprising ulcerative colitis and Crohn's disease, poses a considerable burden on public health. Despite therapeutic advances, persistent inflammation and associated complications underscore the limitations of current medical approaches. Fucoidans, fucose-rich sulfated polysaccharides found in edible brown algae, exhibit promising anti-inflammatory properties. However, variations in bioactivities and efficacy among fucoidans from distinct seaweeds warrant comprehensive investigation. Methods: This study systematically assessed the therapeutic potential of fucoidan extracts from Undaria pinnatifida (UPF) and Fucus vesiculosus (FVF) in a murine model of Dextran Sulfate Sodium (DSS)-induced acute colitis. Daily monitoring of colitis severity, coupled with macroscopic evaluation of collected colons and spleens, provided a comprehensive understanding. Histological scrutiny, utilising Hematoxylin and Eosin (H&E staining), and quantification of cytokines via enzyme-linked immunosorbent assay (ELISA) were integral components of our rigorous methodology Results: Oral administration of UPF and FVF over seven days significantly mitigated body weight loss, improved the Disease Activity Index (DAI), and reduced colon and spleen weight compared to their DSS-treated counterparts. DSS-induced mice exhibited notable histological abnormalities, including loss of crypt architecture, goblet cells, immune cell infiltration, and edema, all of which were effectively reversed by UPF and FVF supplementation. Importantly, the macroscopic improvements correlated with a substantial reduction in the production of 18 pro-inflammatory cytokines in distal colon (DC) tissues. The findings propose the potential of orally administered UPF and FVF as a nutraceutical alternative for IBD treatment This research was funded by Marinova Pty Ltd, Hobart, Australia, grant number 00003944

A fucoidan from sea cucumber Pearsonothuria graeffei with well-repeated structure alleviates gut microbiota dysbiosis and metabolic syndromes in HFD-fed mice.

Fucoidans from Pearsonothuria Graeffei Prevent Obesity by Regulating Intestinal Lipid Metabolism and Inflammation Related Signalling Pathways

Effect of the Sulfation Pattern of Sea Cucumber-Derived Fucoidan Oligosaccharides on Modulating Metabolic Syndromes and Gut Microbiota Dysbiosis Caused by HFD in Mice

Fucosylated Chondroitin Sulfate from Isostichopus Badionotus Alleviates Metabolic Syndromes and Gut Microbiota Dysbiosis Induced by High-Fat and High-Fructose Diet.

Fucoidan and galactooligosaccharides ameliorate high-fat diet-induced dyslipidemia in rats by modulating the gut microbiota and bile acid metabolism

Sargassum fusiforme fucoidan ameliorates diet-induced obesity through enhancing thermogenesis of adipose tissues and modulating gut microbiota

Saccharina japonica fucan suppresses high fat diet-induced obesity and enriches fucoidan-degrading gut bacteria

Fucoidan from Laminaria japonica Ameliorates Type 2 Diabetes Mellitus in Association with Modulation of Gut Microbiota and Metabolites in Streptozocin-Treated Mice

Low molecular weight fucoidan fraction LF2 improves metabolic syndrome via up-regulating PI3K-AKT-mTOR axis and increasing the abundance of Akkermansia muciniphila in the gut microbiota

Fucoidan Alleviates Colitis and Metabolic Disorder by Protecting the Intestinal Barrier, Suppressing the MAPK/NF‐κB Pathways, and Regulating the Gut Microbiota

Anti-Metabolic Syndrome Effects of Fucoidan from Fucus vesiculosus via Reactive Oxygen Species-Mediated Regulation of JNK, Akt, and AMPK Signaling

4-O-sulfation in Sea Cucumber Fucodians Contribute to Reversing Dyslipidiaemia Caused by HFD.

Fucosylated Chondroitin Sulfate Oligosaccharides from Isostichopus Badionotus Regulates Lipid Disorder in C57BL/6 Mice Fed a High-Fat Diet.

Laminaria japonica Polysaccharide Regulates Fatty Hepatosis Through Bile Acids and Gut Microbiota in Diabetes Rat

Metabolomic analysis reveals the potential of fucosylated chondroitin sulfate from sea cucumber in modulating metabolic homeostasis

Sargassum fusiforme fucoidan modifies the gut microbiota during alleviation of streptozotocin-induced hyperglycemia in mice

Fucoidan extracts from Undaria pinnatifida and Fucus vesiculosus mitigate DSS-induced acute colitis in Mice: A Preclinical Investigation

Undaria pinnatifida fucoidan ameliorates dietary fiber deficiency-induced inflammation and lipid abnormality by modulating mucosal microbiota and protecting intestinal barrier integrity

A Combination of Deep-Sea Water and Fucoidan Alleviates T2DM through Modulation of Gut Microbiota and Metabolic Pathways

Fucoxanthin Modulates Cecal and Fecal Microbiota Differently Based on Diet.

Fucoidan modulates gut microbiota and immunity in Peyer's patches against inflammatory bowel disease